University of Manchester - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

University of Manchester - Pharmaceuticals & Healthcare - Deals and Alliances Profile

University of Manchester - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
University of Manchester - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
36 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

University of Manchester (UOM) is an educational and research institution that offers undergraduate, and post graduate masters programs. The university offers courses in accounting and finance; aerospace engineering; computer science; cognitive neuroscience and psychology; economics; learning disability; modern languages and cultures; and psychology; among others. It has over various academic schools and academic and research staff. UOM is a part of Russell Group of universities. The university was a merger of Victoria University of Manchester and the University of Manchester Institute of Science and Technology. It is a member of Universities Research Association group.

University of Manchester - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the compa

  
Source:
Document ID
GDPH142310D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
University of Manchester, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
University of Manchester, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
University of Manchester, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
University of Manchester, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
University of Manchester, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201692
University of Manchester, Pharmaceuticals &Healthcare, Deal Details1122
  Partnerships111
    Orchard Therapeutics Enters into Co-Development Agreement for Transformative Gene Therapies112
    OptiBiotix Health and University of Manchester Form Joint Venture131
    AstraZeneca Enters into Co-Development Agreement with University of Manchestery141
    MedImmune Enters into Research Agreement with University of Manchester151
    MedImmune Enters into Research Agreement with COEBP161
    AstraZeneca Forms Joint Venture with University of Manchester171
    Johnson &Johnson Enters into Co-Development Agreement with University of Manchester181
    Blueberry Therapeutics Enters into Agreement with University of Manchester for Antiflammatory Agents191
    GlaxoSmithKline Enters Into Agreement With Cancer Research Technology And University of Manchester For Cancer Drugs202
    Autifony Therapeutics Enters Into Agreement With Universities Of Manchester And Newcastle To Develop Treatment For Schizophrenia221
    Cancer Research Technology, University of Manchester And AstraZeneca Enters Into Agreement To Develop Cancer Drugs232
    Blueberry Therapeutics Enters into Agreement with University of Manchester and University of Liverpool251
    GlaxoSmithKline, AstraZeneca And The University Of Manchester Form Joint Venture262
  Licensing Agreements281
    Acucela Enters into Licensing Agreement with University of Manchester281
    Basilea Pharma Enters into Licensing Agreement for Novel PanRAF Kinase Inhibitors292
    Curapel Enters into Licensing Agreement with University of Manchester311
  Asset Transactions321
    OptiBiotix Health Acquires Rights to Skin Health Intellectual Property from University of Manchester321
University of Manchester - Key Competitors331
Key Employees341
Locations And Subsidiaries351
  Head Office351
  Other Locations &Subsidiaries351
Appendix361
  Methodology361
  About GlobalData361
  Contact Us361
  Disclaimer361

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "University of Manchester - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/University-of-Manchester-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7724>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). University of Manchester - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/University-of-Manchester-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7724>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research